MTOR and cancer: Multiple signaling pathways, such as PI3K/Akt/mTOR, mitogen-activated protein kinase, and Wnt/β-catenin, are activated by EGFR to enhance proliferation, survival, invasion, and metastasis of cancer cells [17].